Cell-free protein synthesis systems
Provided herein are cell free protein synthesis (CFPS) systems comprising a plurality of ribosomes attached to or encapsulated within a structure, or a plurality of structures, and, optionally, a solid support. Also provided are related kits and uses of the CFPS systems. Methods of producing a protein and methods of treating a disease are provided herein.
1. A reusable cell free protein synthesis (CFPS) system for continuously synthesizing protein at a rate of 1.4×10 −2 mg/hr/μL-2.5 mg/hr/μL, the system comprising a plurality of ribosomes attached to a structure, or a plurality of structures, housed, contained, or attached to a solid support,
wherein the solid support comprises a chamber, at least one fluidic inlet, at least one fluidic outlet, and a solution for containing synthesized protein,
wherein the plurality of ribosomes are positioned between the fluidic inlet and the fluidic outlet, and
wherein the solution comprises one or more in vitro translation reagents and synthesized protein moving through the CFPS system and the synthesized protein is collected through the fluidic outlet.
2. The CFPS system of claim 1 , wherein the solid support is attached to the structure or the plurality of structures.
3. The CFPS system of claim 1 , wherein the structure is a bead, a lattice, an aerogel, foam, or a sponge.
4. The CFPS system of claim 1 , wherein the structure is a bead.
5. The CFPS system of claim 4 , wherein (a) each bead has an average surface area of 300 nm 2 to 4 mm 2 and/or (b) the beads are about the same size or the beads vary in diameter by 60% or more.
6. The CFPS system of claim 4 , wherein the solid support is a vessel.
7. The CFPS system of claim 4 , wherein the bead is encapsulated or suspended within a hydrogel, gelatin, or polymer contained or housed in the solid support.
8. The CFPS system of claim 1 , wherein each structure is attached to the solid support under a controlled condition.
9. The CFPS system of claim 8 , wherein each structure is attached only when a magnetic field is applied to the system.
10. The CFPS system of claim 1 , wherein the ribosomes are eukaryotic ribosomes, or a variant thereof.
11. The CFPS system of claim 1 , wherein the ribosomes are prokaryotic ribosomes, or a variant thereof.
12. The CFPS system of claim 1 , wherein the solid support comprises a plurality of pores.
13. The CFPS system of claim 1 , wherein the structures are attached to only one side of the solid support.
14. A kit comprising the CFPS system of claim 1 and one or more of: a transfer RNA (tRNA), an amino acid, an enzymatic cofactor, and an energy source.
15. The CFPS system of claim 3 , wherein the lattice comprises a plurality of nanowires, nanostrings, or nanothreads.
16. The CFPS system of claim 1 , wherein the ribosomes are present at a density of at least 10 5 ribosomes per cm 2 of the structure.
17. The CFPS system of claim 1 , wherein the ribosomes are present at a density of at least 10 8 ribosomes per cm 2 of the structure.
18. The CFPS system of claim 4 , wherein the average bead size is 10 nm to 1 mm.
19. The reusable CFPS system of claim 1 , wherein the system is a microfluidic system.
20. The reusable CFPS system of claim 1 , wherein the system further comprises a filter to retain the ribosomes in the solid support.
21. The reusable CFPS system of claim 1 , wherein the solution is capable of being cycled back through the fluidic inlet after passing through the fluidic outlet.